Form 8-K - Current report:
SEC Accession No. 0001104659-23-036859
Filing Date
2023-03-27
Accepted
2023-03-27 07:00:28
Documents
14
Period of Report
2023-03-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2310608d1_8k.htm   iXBRL 8-K 26127
2 EXHIBIT 99.1 tm2310608d1_ex99-1.htm EX-99.1 20059
3 GRAPHIC tm2310608d1_ex99-1img001.jpg GRAPHIC 3530
  Complete submission text file 0001104659-23-036859.txt   230900

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fold-20230327.xsd EX-101.SCH 3064
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20230327_lab.xml EX-101.LAB 34477
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20230327_pre.xml EX-101.PRE 22616
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2310608d1_8k_htm.xml XML 3482
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 23761413
SIC: 2834 Pharmaceutical Preparations